Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a growing specialty pharmaceutical dermatology company, based in Canada, on pace to achieve our goal of becoming the best and most customer-centric dermatology company in North America. We are broadening our presence in Canada and aggressively building a commercial infrastructure in the United States by acquiring first- or best-in-class products and transformative compounds that fulfill high unmet medical needs. We have everything it takes – strong financials, a robust and growing product portfolio, and savvy executive leadership.  We currently market 4 brands in Canada including Epuris, Vaniqa, Actikerall and Beteflam.

Participant in Dermatology Update 2018 FALL Meeting:

Missing Event Data